Improve Cell Viability

After three days in the cold, do your cells look like those on the left or those stored in HypoThermosol?

Try BioLife

Interested in evaluating our products? Enter your email address and click "Get a Vial."

CryoStor cryopreservation
freeze media

HypoThermosol hypothermic storage media

Improve Cell Viability

Finally! You can eliminate serum from your freeze media. Discover CryoStor.


Print Friendly
BioLife Solutions manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues, and organs. We perform contract R & D and offer biopreservation protocol consulting. And for select customers, we perform custom formulation, fill, and finish services. More about BioLife →


Pre-formulated with 2, 5, 10%, or a custom volume of USP-grade DMSO, CryoStor yields superior post-thaw cell viability, recovery, and function. Serum-free and protein-free!

Protein-free, serum-free hypothermic storage media are designed for maximum shelf life and shipping stability at 2-8°C.

cGMP cryopreservation media for freezing stem cells isolated from umbilical cord blood, peripheral blood, and bone marrow. Formulated with 55% USP-grade DMSO, 5% USP-grade Dextran, and WFI-quality water.

Biolife CryoQ productCryoQ™
Designed for shipment of small volumes of bio-materials which need to be shipped with dry ice at extremely stable deep-frozen temperatures.

BioLife PHD productPHD™
Designed for the shipment of materials, which must be maintained at 2-8˚C. Ideal for small volume shipments from single dose to 3L in volume. Antifreeze technology eliminates risk of freezing out of 2-8˚C range during shipping.


Contract Research
Leverage our expertise to optimize your biopreservation protocols.

Formulation, Fill, and Finish
Outsource your biopreservation media manufacturing to BioLife.


Distribution Partners


CryoStor versus Alternative Cryopreservation Media

HypoThermosol versus Alternative Hypothermic Storage

BioPreservation Today® Archives

BPT-Fall_2013 vF3C (2)web

Latest News

BioLife Solutions to Present at the 16TH Annual Rodman & Renshaw Global Investment Conference in New York City and the Aegis Healthcare & Technology Conference in Las Vegas Press Release>>

BioLife Solutions CryoStor®and HypoThermosol® Now Embedded in 130 Regenerative Medicine Clinical Trials
Press Release>>

BioLife Solutions Announces Second Quarter 2014 Results Press Release>>

Biolife Solutions Cryostor® Demonstrates Superior Cell Preservation In Multicenter Biobanking Study Press Release>>

See all news >>


IBC’s 4th Annual Cell Therapy Bioprocessing Conference
September 15-16, 2014

Stem Cells & Regenerative Medicine Congress 2014
September 15-16, 2014

12th Annual Cold Chain GDP & Temperature Management Logistics Global Forum

September 29-October 3, 2014

See all events >>


Connect with BioLife